Joon Lee
Stock Analyst at Truist Securities
(4.87)
# 68
Out of 5,182 analysts
116
Total ratings
66.09%
Success rate
50.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $490 → $525 | $426.01 | +23.24% | 5 | Mar 11, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $500 → $700 | $330.99 | +111.49% | 8 | Feb 20, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $201.22 | +14.30% | 4 | Jan 12, 2026 | |
| ARGX argenx SE | Maintains: Buy | $950 → $1,030 | $783.74 | +31.42% | 14 | Jan 8, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $80 → $100 | $53.81 | +85.86% | 4 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $36 → $50 | $6.94 | +620.46% | 4 | Dec 15, 2025 | |
| ALKS Alkermes | Maintains: Buy | $50 → $55 | $33.73 | +63.06% | 3 | Nov 17, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $25 → $14 | $13.04 | +7.36% | 5 | Nov 10, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $100 → $90 | $23.99 | +275.16% | 1 | Nov 5, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $35.40 | +24.29% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $86 | $69.22 | +24.24% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $95 → $75 | $32.99 | +127.38% | 8 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $21 | $10.29 | +104.08% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $150 | $46.22 | +224.53% | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $200 | $187.40 | +6.72% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $50.99 | +135.34% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.44 | +305.41% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $7.50 | +113.33% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $29.27 | +22.99% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.89 | +176.82% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $7.82 | +117.39% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $6.46 | -22.60% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.76 | +378.72% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.93 | +9,456.31% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $66.59 | -48.94% | 1 | Mar 16, 2021 |
Vertex Pharmaceuticals
Mar 11, 2026
Maintains: Buy
Price Target: $490 → $525
Current: $426.01
Upside: +23.24%
Praxis Precision Medicines
Feb 20, 2026
Maintains: Buy
Price Target: $500 → $700
Current: $330.99
Upside: +111.49%
Jazz Pharmaceuticals
Jan 12, 2026
Maintains: Buy
Price Target: $220 → $230
Current: $201.22
Upside: +14.30%
argenx SE
Jan 8, 2026
Maintains: Buy
Price Target: $950 → $1,030
Current: $783.74
Upside: +31.42%
BioMarin Pharmaceutical
Dec 23, 2025
Maintains: Buy
Price Target: $80 → $100
Current: $53.81
Upside: +85.86%
Wave Life Sciences
Dec 15, 2025
Maintains: Buy
Price Target: $36 → $50
Current: $6.94
Upside: +620.46%
Alkermes
Nov 17, 2025
Maintains: Buy
Price Target: $50 → $55
Current: $33.73
Upside: +63.06%
Intellia Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $25 → $14
Current: $13.04
Upside: +7.36%
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $23.99
Upside: +275.16%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $35.40
Upside: +24.29%
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $69.22
Upside: +24.24%
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $32.99
Upside: +127.38%
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $10.29
Upside: +104.08%
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $46.22
Upside: +224.53%
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $187.40
Upside: +6.72%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $50.99
Upside: +135.34%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $4.44
Upside: +305.41%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $7.50
Upside: +113.33%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $29.27
Upside: +22.99%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.89
Upside: +176.82%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.82
Upside: +117.39%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $6.46
Upside: -22.60%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.76
Upside: +378.72%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $2.93
Upside: +9,456.31%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $66.59
Upside: -48.94%